Work

A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group Study (GOG 146Q)

Year: 2010

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2010.11.008

Authors: Thomas J. Herzog, Michael W. Sill, Joan L. Walker, David O'Malley, Mark Shahin, Koen DeGeest, Sheldon A. Weiner, David Mutch, Robert L. DeBernardo, Samuel S. Lentz

Institutions: NewYork–Presbyterian Hospital, Columbia University Irving Medical Center, Columbia University, Roswell Park Comprehensive Cancer Center, University at Buffalo, State University of New York, University of Oklahoma, The Ohio State University, Abington Memorial Hospital, University of Iowa Hospitals and Clinics, Corewell Health William Beaumont University Hospital, Washington University in St. Louis, University Hospitals of Cleveland, University Hospitals Cleveland Medical Center, Wake Forest University

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G1950154987, GYNECOLOGIC ONCOLOGY GROUP STATISTICAL AND DATA CENTER, Gynecologic Oncology Group, G70736214

OpenAlex ID: W1978453679

FWCI: 3.248

Cites: 26

Cited by: 24

Related to: 10